IP Library Assignment 074195/0008
Patent Assignment
Reel/Frame 074195/0008

Assignment of Assignor's Interest

Recorded: 2026-03-26 Pages: 12
Assignor
ZEVRA THERAPEUTICS, INC.
Executed: 2026-03-13
Assignee
COMMAVE THERAPEUTICS SA
AVENUE GIUSEPPE-MOTTA 31-37, GENÈVE, 1202, SWITZERLAND
Covered Properties (11)
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application: 16/431,275 →
Publication: US 2019/0284166
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application: 16/431,422 →
Publication: US 2019/0282559
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application: 16/431,468 →
Publication: US 2020/0061198
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application: 16/577,876 →
Publication: US 2020/0016272
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application: 16/577,946 →
Publication: US 2020/0016273
Compositions Comprising Methlphenidate-Prodrugs, Processes of Making and Using the Same
Application: 16/588,914 →
Publication: US 2020/0062731
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application: 16/793,923 →
Publication: US 2020/0181113
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application: 16/794,170 →
Publication: US 2020/0181114
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application: 17/115,425 →
Publication: US 2021/0130322
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application: 62/432,675 →
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 25, 2019
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 049580/0874 →
Assignment of Assignor's Interest Jun 26, 2019
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 049596/0072 →
Assignment of Assignor's Interest Jun 26, 2019
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 049596/0001 →
Assignment of Assignor's Interest Jun 26, 2019
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 049595/0922 →
Corrective Assignment to Correct the Page 2 Was Omitted Previously Recorded at Reel: 49580 Frame: 874. Assignor(S) Hereby Confirms the Assignment. Jul 18, 2019
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 051540/0399 →
Assignment of Assignor's Interest Dec 11, 2019
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 051245/0645 →
Assignment of Assignor's Interest Sep 23, 2020
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 053863/0418 →
Assignment of Assignor's Interest Sep 23, 2020
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 053863/0377 →
Assignment of Assignor's Interest Jan 14, 2021
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 054919/0858 →
Assignment of Assignor's Interest Jan 14, 2021
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 054919/0909 →
Assignment of Assignor's Interest Jan 14, 2021
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 054920/0066 →
Change of Name Feb 26, 2024
From: KEMPHARM, INC.
To: ZEVRA THERAPEUTICS, INC.
Reel/Frame 066679/0668 →
Security Interest Apr 8, 2024
From: ZEVRA THERAPEUTICS, INC.
To: ALTER DOMUS (US) LLC
Reel/Frame 067040/0637 →
Release of Security Interest Mar 13, 2026
From: ALTER DOMUS (US) LLC
To: ZEVRA THERAPEUTICS, INC.
Reel/Frame 075080/0907 →
Change of Name Mar 25, 2026
From: KEMPHARM, INC.
To: ZEVRA THERAPEUTICS, INC.
Reel/Frame 075243/0008 →
Assignment of Assignor's Interest Mar 25, 2026
From: ZEVRA THERAPEUTICS, INC.
To: COMMAVE THERAPEUTICS SA
Reel/Frame 074186/0531 →
Assignment of Assignor's Interest Mar 26, 2026
From: ZEVRA THERAPEUTICS, INC.
To: COMMAVE THERAPEUTICS SA
Reel/Frame 074195/0601 →